- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PF-299804
Total 1611 results
-
PfizerCompleted
-
PfizerTerminatedIntracerebral HemorrhageSpain, United States, Canada, United Kingdom
-
PfizerCompleted
-
PfizerCompleted
-
PfizerCompletedSchizophrenia | Schizo-affective DisorderSouth Africa
-
PfizerTerminated
-
PfizerCompletedReduction of Hypertrophic Skin ScarringUnited States, Germany, Hungary, Spain
-
PfizerTerminatedHypertrophic Scars Resulting From Prior Breast Scar Revision SurgeryUnited States
-
PfizerCompleted
-
PfizerCompleted
-
PfizerCompleted
-
PfizerCompleted
-
Duke UniversityPfizerCompletedColorectal CancerUnited States
-
PfizerCompletedAlzheimer's DiseaseKorea, Republic of, Canada, United States, Australia, United Kingdom, Belgium
-
PfizerTerminated
-
PfizerCompletedHepatitis C VirusUnited States
-
Seoul National University HospitalRecruitingPediatric SedationKorea, Republic of
-
PfizerTerminated
-
PfizerRecruitingSmall Cell Lung Cancer (SCLC) | Follicular Lymphoma (FL) | Castration Resistant Prostate Cancer (CRPC)United States, Spain, Korea, Republic of, Poland, China, Bulgaria, Russian Federation, Japan
-
University Health Network, TorontoPfizerCompleted
-
PfizerNot yet recruiting
-
Thomas LundPfizerNot yet recruiting
-
Emma GuttmanPfizerRecruiting
-
Massachusetts General HospitalRecruiting
-
University of Milano BicoccaPfizerRecruitingAnaplastic Large Cell Lymphoma, ALK-PositiveItaly
-
PfizerActive, not recruitingDuchenne Muscular DystrophyUnited States, Spain, Belgium, Korea, Republic of, Taiwan, Canada, Australia, Germany, Japan, France, Italy, United Kingdom, Russian Federation, Israel, Switzerland
-
PfizerCompletedHealthy Volunteers | Hepatic ImpairmentUnited States
-
PfizerCompleted
-
PfizerCompletedHealthy ParticipantsUnited States
-
Maastricht University Medical CenterPfizerCompleted
-
PfizerCompletedHealthy | Sickle Cell AnemiaUnited States
-
PfizerCompleted
-
Yale UniversityNational Institute on Drug Abuse (NIDA)CompletedCannabis DependenceUnited States
-
University of ZurichPfizerCompletedDecision MakingSwitzerland
-
PfizerCompleted
-
PfizerCompleted
-
BiogenCompleted
-
PfizerTerminated
-
PfizerCompleted
-
PfizerCompletedPharmacokinetics | Safety | Phase 1 | Single Dose | TolerationBelgium
-
PfizerCompletedDiabetes Mellitus, Type IIBelgium
-
PfizerCompleted
-
PfizerCompleted
-
PfizerActive, not recruitingBreast Cancer | Small Cell Lung Cancer | Ovarian CancerUnited States, China, Japan, Mexico, Bulgaria, Argentina
-
PfizerCompletedType 2 Diabetes MellitusJapan
-
PfizerCompletedUlcerative ColitisUnited States, Spain, Israel, Korea, Republic of, Russian Federation, Turkey, Czechia, Hungary, Italy, Poland, Bulgaria, Denmark, Germany, Serbia, Austria, Slovakia, Ukraine, Georgia, Romania
-
PfizerCompleted